Cargando…

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience

Detalles Bibliográficos
Autores principales: Lin, Li-Ching, Huang, Wen-Kuan, Yen, Chueh-Chuan, Yang, Ching-Yao, Sung, Meng-Ta, Wong, Natalie S.M., Chua, Daniel T. T., Lee, Sarah W. M., Chen, Jen-Shi, Yeh, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612116/
https://www.ncbi.nlm.nih.gov/pubmed/36313668
http://dx.doi.org/10.3389/fonc.2022.1028118
_version_ 1784819699190595584
author Lin, Li-Ching
Huang, Wen-Kuan
Yen, Chueh-Chuan
Yang, Ching-Yao
Sung, Meng-Ta
Wong, Natalie S.M.
Chua, Daniel T. T.
Lee, Sarah W. M.
Chen, Jen-Shi
Yeh, Chun-Nan
author_facet Lin, Li-Ching
Huang, Wen-Kuan
Yen, Chueh-Chuan
Yang, Ching-Yao
Sung, Meng-Ta
Wong, Natalie S.M.
Chua, Daniel T. T.
Lee, Sarah W. M.
Chen, Jen-Shi
Yeh, Chun-Nan
author_sort Lin, Li-Ching
collection PubMed
description
format Online
Article
Text
id pubmed-9612116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96121162022-10-28 Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience Lin, Li-Ching Huang, Wen-Kuan Yen, Chueh-Chuan Yang, Ching-Yao Sung, Meng-Ta Wong, Natalie S.M. Chua, Daniel T. T. Lee, Sarah W. M. Chen, Jen-Shi Yeh, Chun-Nan Front Oncol Oncology Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9612116/ /pubmed/36313668 http://dx.doi.org/10.3389/fonc.2022.1028118 Text en Copyright © 2022 Lin, Huang, Yen, Yang, Sung, Wong, Chua, Lee, Chen and Yeh https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Lin, Li-Ching
Huang, Wen-Kuan
Yen, Chueh-Chuan
Yang, Ching-Yao
Sung, Meng-Ta
Wong, Natalie S.M.
Chua, Daniel T. T.
Lee, Sarah W. M.
Chen, Jen-Shi
Yeh, Chun-Nan
Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title_full Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title_fullStr Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title_full_unstemmed Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title_short Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
title_sort corrigendum: compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: taiwan and hong kong experience
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612116/
https://www.ncbi.nlm.nih.gov/pubmed/36313668
http://dx.doi.org/10.3389/fonc.2022.1028118
work_keys_str_mv AT linliching corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT huangwenkuan corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT yenchuehchuan corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT yangchingyao corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT sungmengta corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT wongnataliesm corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT chuadanieltt corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT leesarahwm corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT chenjenshi corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience
AT yehchunnan corrigendumcompassionateuseofripretinibforpatientswithmetastaticgastrointestinalstromaltumorstaiwanandhongkongexperience